Now Accepting Speaker Proposals  Submit a Proposal

Conference Programs

Mon, Oct 4 & Tue AM, Oct 5

Bispecific Antibodies for Cancer Immunotherapy Bispecific Antibodies for Cancer Immunotherapy
Immuno-Oncology Biomarkers Immuno-Oncology Biomarkers
Cell-Based Immunotherapies Cell-Based Immunotherapies

Tue PM, Oct 5 & Wed Oct 6

Emerging Targets for Immunomodulatory Antibodies Emerging Targets for Immunomodulatory Antibodies
Preclinical and Translational Immuno-Oncology Preclinical and Translational Immuno-Oncology
Oncolytic Virus Immunotherapy Oncolytic Virus Immunotherapy

Immuno-Oncology Summit

Over the past 9 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI's IO Summit provides.


Register with Confidence

Select an In-person or virtual option, and you have the flexibility to switch your preferred event experience at any time leading up to the conference. Our flexible registration is designed to take the uncertainties out of these uncertain times.

EVENT AT-A-GLANCE
FAQs

2020 Featured Speakers

Roy Baynes
Senior VP and Head, Global Clinical Development, CMO, Merck

Marcus Bosenberg
Interim Director, Yale Center for Immuno-Oncology, Yale Univ.

Dean Bottino
Sr. Scientific Director, Clinical Translational Modeling, Takeda

Virna Cortez-Retamozo
Lab Head, Oncology-Pharmacology, Sanofi

David Fontana
VP, Cell Therapy Franchise, Juno Therapeutics, a Bristol Myers Squibb Co.

Adil Daud
Director, Melanoma Clinical Research, UCSF Helen Diller Family Comprehensive Cancer Center

Cara Haymaker
Director, Oncology Research and Immuno-Monitoring Core (ORION), Univ. of Texas MD Anderson Cancer Center

Howard L. Kaufman
Head, R&D, Immuneering; Massachusetts General Hospital

Keith Knutson
Director, Immunology & Immunotherapy, Mayo Clinic

Ravi Madan
Clinical Director, Genitourinary Malignancies Branch, NCI NIH

Robert Pierce
CSO, Sensei Biotherapeutics

David A. Reardon
Clinical Director, Center for Neuro-Oncology, Dana-Farber Cancer Institute

Andrew Weinberg
Chief, Laboratory of Basic Immunology, Providence Health & Services

Theresa Whiteside
Professor, Pathology, Immunology, Univ. of Pittsburgh School of Medicine

Michael Woo
Head, Search & Evaluation, Novartis


TALKS AVAILABLE ON-DEMAND




Become a Sponsor or Exhibitor

Whether you’re targeting the entire conference community of life sciences, pharmaceutical, clinical, healthcare, and IT professionals, a topic-specific community, a specific individual, or high-level decision makers, we offer a variety of methods to access our esteemed delegates. Explore our sponsor or exhibitor packages which offer a wide range of platforms to launch products, gain exposure, collect feedback, network and generate new leads.


LEARN MORE
DOWNLOAD PROSPECTUS

Connect With Us

MEETING SUGGESTIONS

For meeting questions or suggestions, please contact:

Virginia Maxwell
Senior Associate Producer
Cambridge Healthtech Institute
vmaxwell@healthtech.com

PARTNERING & SPONSORSHIP

For partnering and sponsorship info, please contact:

Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
+1 781.247.6286
reymael@healthtech.com

MEDIA & ASSOCIATION

For media and association partnerships, please contact:

Christine Benners
Sr. Marketing Manager
Cambridge Healthtech Institute
+1 781.247.1820
cbenners@healthtech.com